2-27137759-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000335524.7(PRR30):c.571G>A(p.Val191Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000149 in 1,613,696 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000335524.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRR30 | NM_178553.4 | c.571G>A | p.Val191Met | missense_variant | 3/3 | ENST00000335524.7 | NP_848648.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRR30 | ENST00000335524.7 | c.571G>A | p.Val191Met | missense_variant | 3/3 | 1 | NM_178553.4 | ENSP00000335017 | P1 | |
PRR30 | ENST00000432962.2 | c.77G>A | p.Ser26Asn | missense_variant | 4/4 | 3 | ENSP00000393468 |
Frequencies
GnomAD3 genomes AF: 0.0000985 AC: 15AN: 152236Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000240 AC: 6AN: 249530Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 134976
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461460Hom.: 0 Cov.: 33 AF XY: 0.00000963 AC XY: 7AN XY: 726974
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152236Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74364
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 21, 2021 | The c.571G>A (p.V191M) alteration is located in exon 3 (coding exon 1) of the PRR30 gene. This alteration results from a G to A substitution at nucleotide position 571, causing the valine (V) at amino acid position 191 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at